Generation of mouse models carrying B cell restricted single or multiplexed loss-of-function mutations through CRISPR-Cas9 gene editing. Academic Article uri icon

Overview

abstract

  • Here, we present a protocol to generate B cell restricted mouse models of loss-of-function genetic drivers typical of lymphoproliferative disorders, using stem cell engineering of murine strains carrying B cell restricted Cas9 expression. We describe steps for preparing lentivirus expressing sgRNA-mCherry, isolating hematopoietic stem and progenitor cells, and in vitro transduction. We then detail the transplantation of engineered cells into recipient mice and verification of gene edits. These mouse models represent versatile platforms to model complex disease traits typical of lymphoproliferative disorders. For complete details on the use and execution of this protocol, please refer to ten Hacken et al.,1 ten Hacken et al.,2 and ten Hacken et al.3.

authors

  • ten Hacken, Elisa
  • Gruber, Michaela
  • Hernández-Sánchez, María
  • Hoffmann, Gabriela Brunsting
  • Baranowski, Kaitlyn
  • Redd, Robert A
  • Clement, Kendell
  • Livak, Kenneth
  • Wu, Catherine J

publication date

  • September 18, 2023

Research

keywords

  • Gene Editing
  • Lymphoproliferative Disorders

Identity

PubMed Central ID

  • PMC10510057

Scopus Document Identifier

  • 85171279605

Digital Object Identifier (DOI)

  • 10.1016/j.xpro.2023.102165

PubMed ID

  • 37729058

Additional Document Info

volume

  • 4

issue

  • 4